FS KKR Capital: Better High-Yield Options In The Sector (Rating Downgrade)
FS KKR Capital Corp's credit quality has improved, but lingering borrower issues and economic uncertainty prompt a downgrade from buy to hold. Despite a 13% yield, FSK's non-accruals remain high, and a potential recession could further impact their financial stability and dividend safety. FSK's net asset value has declined significantly, and their dividend could be at risk if economic conditions worsen.
Improving Outlook At KKR Real Estate Finance Trust
Trailing dividend of $1.00 or 9.06%. Improvements in commercial real estate are creating portfolio stabilization at KREF (100% of loans performing as of Feb 2025). Management targeting portfolio growth.
KKR.PR.D: 6.25% Mandatory Convertible Preferred Stock IPO From KKR & Co.
KKR & Co. Inc. has issued a 6.25% Series D Mandatory Convertible Preferred Stock, trading at $49.36 with a Yield to Maturity of 6.98%. The new preferred stock is not rated by S&P, Moody's, or Fitch, and will convert based on KKR's average stock price before March 1, 2028. KKR-D is expected to align closely with KKR's common stock price, offering potential arbitrage opportunities when deviating.
Exclusive: KKR, Warburg Pincus group submitted non-binding bid for Gerresheimer, sources say
A consortium including KKR and Warburg Pincus has submitted a non-binding bid for Gerresheimer AG , which makes pens used to inject weight loss drugs like Wegovy, two people with knowledge of the matter said.
FS KKR Capital: Buy The Drop, Lock In A 13% Yield
FS KKR Capital offers high dividend income and upside revaluation potential, trading at only a slight premium to its 3-year average P/NAV ratio. I rate FS KKR Capital a strong buy due to its potential to move towards healthier balance sheet quality and lower its non-accrual percentage. FS KKR Capital under-earned its regular dividend with NII in the last quarter as its non-accrual percentage increased slightly Q/Q.
Warburg Pincus, KKR in talks to buy medical packaging maker Gerresheimer, Bloomberg News reports
A consortium consisting of Warburg Pincus and KKR are in talks to acquire German medical packaging maker Gerresheimer AG , Bloomberg News reported on Wednesday citing people familiar with the matter.
Trade Tracker: Bryn Talking buys KKR and Apollo
Bryn Talkington, Managing Partner of Requisite Capital Management, joins CNBC's "Halftime Report" to explain why she's buying these stocks after they've fallen so far.
FS KKR Capital: The Discount Is Not Enough, And Dividend Cut Likely
Before FSK circulated its Q4 report, I issued a bearish piece, realizing my 27% returns and suggesting investors to avoid the investment. Since then the share price has increased by 5%, but the underlying fundamentals have become worse. Plus, Q4 was a miss. In this article I explain in more details why I still recommend investors to think twice before deploying capital in FSK stock.
Assura board accepts £1.6bn offer from KKR consortium
Assura Group (LSE:AGR) told investors it "would be minded" to accept a £1.6 billion takeover bid from KKR and Stonepeak Partners. Having rejected several previous offers, the board of the UK healthcare property investor said the consortium has now upped its bid to a potential cash offer of 49.4p per share.
UK's Assura in talks with KKR consortium for $2.08 billion offer
British healthcare real estate investment trust Assura on Monday said it will likely consider a 1.61 billion pounds ($2.08 billion) offer from KKR and Stonepeak Partners, after rejecting four previous offers from another KKR-led consortium.
KKR: Overreaction To Modest Dilution Creates Opportunity (Rating Upgrade)
KKR shares have dropped over 25% in 2025, but are still up 21% from last year due to strong financial results. KKR's issuance of mandatory convertible preferred shares aims to raise $1.5 billion, diluting shareholders by about 1% to invest in Strategic Holdings. Strategic Holdings' aggressive growth targets add complexity and potential volatility to KKR's earnings, raising concerns among investors.
CapEx slow down in Mexico is manifesting itself right now, says KKR's Henry McVey
Henry McVey, KKR head of the global macro, balance sheet and risk teams, joins 'The Exchange' to discuss the facts on tariffs, where businesses are moving production, and if the market's reaction makes sense.
